Reza Mehrazin, MD
Disclosures: I/we have no financial relationships to report.

http://geriatric-palliative-boardreview.org/sites/default/files/classimages/reza.png

 

Reza Mehrazin, MD

Associate Professor

Department of Urology

Mount Sinai Beth Israel

Mount Sinai St. Lukes - Mount Sinai West

Icahn School of Medicine at Mount Sinai

Mount Sinai Health System

 

Dr. Mehrazin joined the surgical staff at Mount Sinai after completing a two-year Society of Urologic Oncology (SUO) accredited fellowship at a highly prestigious National Cancer Institute (NCI) designated cancer center, Fox Chase Cancer Center. Prior to his fellowship, he completed his general surgery internship and urology residency at University of Tennessee Health Science Center.

 

Dr. Mehrazin’s clinical expertise is in open, laparoscopic, and robotic surgical techniques for the treatment of various urologic cancers, which allows him to tailor a specific treatment plan based on individual patient need and preferences. He is one of the few urologists in the region who has extensive training and is certified in performing minimally invasive organ preserving and reconstructive techniques to preserve function and quality of life for patients with kidney cancer and bladder cancer. He performs both robotic and open cystectomies with continent urinary diversion (new bladder), nephron-sparing (kidney preserving) partial nephrectomy, nerve-sparing prostatectomy, partial or total adrenalectomy, retroperitoneal lymph node dissection for testicular cancer, and endoscopic nephron-sparing management of patients with upper tract urothelial carcinomas. He also has a special clinical interest in the management of patients with metastatic and advanced kidney cancer with tumors extending into the surrounding organs or major vessels, as well as salvage bladder surgeries following radiation therapy.

 

His research interests revolve around novel clinical and surgical treatment of kidney and bladder cancer. Over 170 of his abstracts have been presented at international, national, and regional scientific meetings. He has authored and co-authored over 50 scientific papers which are published or currently in press in major, high impact journals, such as The Journal of Urology, European Urology, and Urologic Oncology. He has also served as an expert reviewer and medical correspondence writer for medical journals such as UroToday, World Journal of Urology, and International Urology & Nephrology.